Abstract
A lacZ transgene, expressed by the myogenin promoter, was introduced into the mouse hypoxanthine phosphoribosyltransferase (Hprt) locus by gene targeting in embryonic stem cells. Embryos between E10.5-E18.5 days were analyzed for expression of the transgene after staining for beta-galactosidase activity. Transgene expression was restricted to the skeletal muscle lineages reflecting a similar temporal and spatial pattern previously demonstrated for the endogenous myogenin gene. Additionally, a second transgene, MC1tk, showed expression in 87% of the clones when targeted to Hprt. This strategy, called targeted transgenesis, provides control for analyzing promoter sequences and for comparing various transgenes expressed by the same promoter.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Arabinofuranosyluracil / analogs & derivatives
-
Arabinofuranosyluracil / pharmacology
-
Gene Expression Regulation, Developmental / genetics
-
Gene Targeting* / methods
-
Herpesvirus 1, Human / enzymology
-
Herpesvirus 1, Human / genetics
-
Histocytochemistry
-
Hypoxanthine Phosphoribosyltransferase / genetics*
-
Lac Operon / genetics*
-
Mice
-
Mice, Transgenic
-
Muscle Proteins / genetics
-
Muscle, Skeletal / metabolism
-
Myogenin / genetics*
-
Promoter Regions, Genetic
-
Stem Cells / metabolism
-
Thymidine Kinase / genetics
-
X Chromosome / genetics
Substances
-
Muscle Proteins
-
Myog protein, mouse
-
Myogenin
-
Arabinofuranosyluracil
-
fialuridine
-
Hypoxanthine Phosphoribosyltransferase
-
Thymidine Kinase